Home > Boards > US Listed > Biotechs >

Crispr Therapeutics AG (CRSP)

CRSP RSS Feed
Add CRSP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/16/2022 9:25:06 AM - Followers: 53 - Board type: Free - Posts Today: 0

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
CRSP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CRSP News: Evercore ISI Keeps a Buy Rating on Crispr Therapeutics AG (CRSP) 08:06 PM
CRSP News: Current Report Filing (8-k) 05/16/2022 12:26:08 PM
CRSP News: CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer 05/16/2022 12:01:00 PM
CRSP News: William Blair Thinks Crispr Therapeutics AG’s Stock is Going to Recover 05/15/2022 06:16:31 AM
CRSP News: Brookline Capital Markets Thinks Crispr Therapeutics AG’s Stock is Going to Recover 05/12/2022 12:55:09 PM
PostSubject
#121   I added CRSP as a new position at OldAIMGuy 05/16/22 09:25:06 AM
#120   Speaking of anti-CD70 CAR-T's https://www.sciencedirect.com/science/article/abs jondoeuk 05/12/22 06:07:16 PM
#119   EHA PR https://www.globenewswire.com/news-release/2022/05/12/2442178/0/en/CRISPR jondoeuk 05/12/22 02:20:20 PM
#118   As for edits, knockouts (in addition to CD70) jondoeuk 04/17/22 06:07:32 PM
#117   They are also working with NKTX on three jondoeuk 04/17/22 06:05:09 PM
#116   The company hopes to have an R&D Day jondoeuk 04/17/22 06:02:17 PM
#115   My day order to buy CRSP at $65.40 JJ8 04/06/22 01:29:15 PM
#114   The company has expanded the CTX110 trial to jondoeuk 03/23/22 05:39:44 PM
#113   Based on CTX110's data. I view it as jondoeuk 10/12/21 08:08:17 PM
#112   I bought the AH dip without knowing what Cosa 10/12/21 05:04:23 PM
#111   PR https://www.globenewswire.com/news-release/2021/10/12/2312955/0/en/CRISPR-The jondoeuk 10/12/21 04:57:51 PM
#110   CTX-110 clinical data event (Oct 12) https://www.veracast.com/webcasts/clients/w jondoeuk 10/05/21 06:47:14 PM
#109   SITC: CRSP presentation: jondoeuk 10/01/21 12:23:33 PM
#108   CRISPR Therapeutics to Participate in the Chardan's 5th WebSlinger 09/28/21 08:25:14 AM
#107   Could be time to bail, or short! Cburg 09/19/21 07:18:55 PM
#106   The company anticipates filing of lead candidate CTX-001 jondoeuk 08/06/21 05:42:47 PM
#105   Head n shoulders pattern back then starkd748 08/06/21 03:24:14 PM
#104   When I posted that warning on July 6, conix 08/05/21 02:55:58 PM
#103   You were compelling. You influenced me to sell! DAMN traderbbc1 08/05/21 09:48:19 AM
#102   They also have a number of collaboration, one jondoeuk 07/30/21 03:52:02 PM
#101   This publication includes information on the company's development jondoeuk 07/30/21 03:47:01 PM
#100   Covered at $121 from $155. conix 07/29/21 10:32:33 PM
#99   For full discloser, are you short CRSP? traderbbc1 07/29/21 08:07:41 PM
#98   Crispr Therapeutics: Get Ready To Bail Out conix 07/06/21 10:57:46 AM
#97   Yeah, I checked the price this morning and WebSlinger 06/30/21 11:55:08 AM
#96   Some big buys coming in today. $CRSP Howard Roark 06/30/21 11:48:33 AM
#95   This is from today's ARK Investments weekly newsletter: WebSlinger 06/28/21 08:15:09 AM
#94   It looks like it is going to be WebSlinger 06/28/21 08:08:41 AM
#93   Intellia Shares Climb on Positive Gene-Editing Data JohnLocke101 06/28/21 07:28:05 AM
#92   Breaking through that 136.00 resistance level. $CRSP Howard Roark 06/24/21 12:26:58 PM
#91   ASCO abstract (TIP) https://meetinglibrary.asco.org/record/201308/abstract jondoeuk 05/27/21 12:53:37 PM
#90   Link to the webcast https://www.veracast.com/webcasts/clients/webcasts/218Uf0.cf jondoeuk 05/19/21 09:50:38 PM
#89   Some preclinical data from NKTX last year https://www.nkartatx.com/file.cfm/75/d jondoeuk 05/15/21 01:35:30 PM
#88   In case you weren't aware https://www.globenewswire.com/news-release/2021/05/06 jondoeuk 05/14/21 04:46:39 PM
#87   And here I thought I got a great JohnLocke101 05/11/21 03:06:51 PM
#86   Started a position here at $0.94 USD pre-market Nosnibor 05/11/21 01:04:46 PM
#85   Jumped in big on this dip. JohnLocke101 05/10/21 11:12:05 AM
#84   Crisper looking like a steal at these levels imo Howard Roark 05/09/21 10:12:50 PM
#83   Lic. deal! So smart. Less $ out of traderbbc1 05/06/21 04:26:39 PM
#82   I agree! JohnLocke101 05/06/21 04:13:38 PM
#81   Crispr Therapeutics is a screaming f#&*in buy here. oldmusky 05/06/21 11:37:18 AM
#80   Blew through that 50 DMA this morning $CRSP Howard Roark 04/26/21 12:04:55 PM
#79   CRISPR Therapeutics Is Upgraded After $900 Million Deal crudeoil24 04/21/21 10:29:15 AM
#78   These edits could be added to not only jondoeuk 04/10/21 03:43:22 PM
#77   The poster https://crisprtx.gcs-web.com/static-files/9ca42ab8-38e2-49d5-8919-194 jondoeuk 04/10/21 03:42:33 PM
#76   Other potential improvements being explored are TET2 disruption jondoeuk 04/03/21 09:02:12 PM
#75   Bounce off of the 200dma? JohnLocke101 03/25/21 06:17:58 AM
#74   From AACR: jondoeuk 03/10/21 07:03:01 PM
#73   I think it is likely that 100, today’s sokol 03/05/21 04:29:13 PM
#72   ...and the bottom is ??? slicknick617 03/04/21 08:19:54 PM
PostSubject
Consent Preferences